Cost-effectiveness analysis of neoadjuvant pertuzumab and trastuzumab therapy for locally advanced, inflammatory, or early HER2-positive breast cancer in Canada
暂无分享，去创建一个
G. Wells | S. Dent | P. Thuresson | A. N. Pepper | M. Thompson | A. Paterson | S. Yunger | C. Attard | S. Brown | G. A. Wells | Attard Cl | Pepper An | Brown St | Thuresson Po | Paterson Ah